Protean BioDiagnostics
PrivateLast Round
Debt
Sep 16, 2025
Total Funding Raised
$300,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Protean BioDiagnostics is a biotechnology company that provides precision oncology diagnostic services, including digital pathology, molecular diagnostics, and AI-driven clinical trial matching for community cancer centers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protean BioDiagnostics Comparables
Compare Protean BioDiagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoHost | 79% | |
| OncoDNA | 77% | |
| Roche Holding | 75% |
Protean BioDiagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 16, 2025 | ||||
| Accelerator | Mar 11, 2019 |
Key People
Founding team and executive leadership
Protean BioDiagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tampa Bay Technology Incubator | Accelerator |
| Small Business Administration | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
$300K round from Small Business Administration
- May 8, 2024
Grew 16% QoQ, from 19 to 22 employees.
Protean BioDiagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Protean BioDiagnostics's valuation, stock price, and market status.
Is Protean BioDiagnostics a public or private company?
Protean BioDiagnostics is a private company.
What is the current stock price of Protean BioDiagnostics?
Protean BioDiagnostics is a private company with no public stock price. Caplight tracks Protean BioDiagnostics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Protean BioDiagnostics worth (valuation)?
Valuation information for Protean BioDiagnostics is not publicly available.
Can I buy Protean BioDiagnostics stock?
Protean BioDiagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Protean BioDiagnostics's last funding round?
Protean BioDiagnostics's most recent funding round was Debt on September 16, 2025.
Who are the main investors in Protean BioDiagnostics?
Key investors in Protean BioDiagnostics include Tampa Bay Technology Incubator, Small Business Administration.
Will Protean BioDiagnostics IPO soon?
No public IPO plans have been announced for Protean BioDiagnostics.
How can I track Protean BioDiagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Protean BioDiagnostics's secondary market activity and sign up for updates.